Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Alzheimer’s Disease
Anxiety
Bipolar Disorder
Depression
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
JCP Podcast
Rounds in the General Hospital
View All
Paul P. Yeung, MD, MPH
JCP
Original Research
Xanomeline and Trospium Chloride for Agitation Associated With Schizophrenia
March 24, 2025
Xanomeline and trospium showed improvement in agitation as measured by the PANSS-Excited Component in participants with acute exacerbations of schizophrenia.
Paul P. Yeung
,
Alan Breier
,
Haiyuan Zhu
, et al
JCP
Original Research
Adjunctive Cariprazine for MDD With Inadequate Response to Antidepressants
August 16, 2023
This study assessed the efficacy of adjunctive use of cariprazine, an atypical antipsychotic, in MDD patients with inadequate response to antidepressants.
Robert Riesenberg
,
Paul P. Yeung
,
Ludmyla Rekeda
, et al
JCP
Original Research
A Randomized, Double-Blind, Placebo-Controlled Trial of Desvenlafaxine Succinate in Adult Outpatients With Major Depressive Disorder
November 15, 2007
Michael R. Liebowitz
,
Paul P. Yeung
,
Richard Entsuah
JCP
Original Research
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Desvenlafaxine Succinate in the Treatment of Major Depressive Disorder
May 15, 2007
Nicholas A. DeMartinis
,
Paul P. Yeung
,
Richard Entsuah
, et al
